Antwerp
Belgium
43rd Congress
of the European Society
of Surgical Oncology
2 – 4 OCTOBER 2024
Surgical Oncology Tomorrow: Innovation & Education
www.esso43.org
#ESSO43
Antwerp
Belgium
43rd Congress
of the European Society
of Surgical Oncology
2 – 4 OCTOBER 2024
Surgical Oncology Tomorrow: Innovation & Education
www.esso43.org
#ESSO43
Call for abstracts
Authors are strongly advised to submit prior to the deadline and avoid unnecessary delays.
For any abstract related queries please contact the ESSO secretariat.
Abstract submission will close on
Wednesday, 15 May 2024
Abstract Guidelines
Language
The abstract must be submitted in good English. The Scientific Committee reserves the right to reject abstracts presented in poor English or request an immediate revision by the presenting author.
Author and Co-Authors
No more than 20 authors can be listed. E-mail address, institutional affiliation, city, and country must be filled in. For cooperative study groups, the group’s name should be used instead of individual institutional affiliations or include the group’s name in the abstract’s title.
Abstract Title
The title of the abstract should be concise and accurately describe the study undertaken. Do not use non-standard abbreviations and commercial names (generic names only).
Abstract Structure
Abstracts should be structured to include the following 4 sections:
- Background: introductory sentence specifying the purpose of the study
- Material and methods: a brief description of relevant experimental procedures
- Results: summary of the results of the investigation
- Conclusions: a statement of the main conclusions
Restrictions
The abstract submission system will not accept abstracts that exceed 2900 characters (including the body of the abstract, spaces and 1 table).
Only one data table is permitted in the body of the abstract. Illustrations and figures are not allowed and will be deleted if submitted.
Abbreviations
Abbreviations may be used if standard or if spelt out and defined at the first use. Compounds should be mentioned with the generic name, in lower cases. Commercial names are admitted in the text, with an ®, and if in brackets following the generic name, i.e., “generic (Commercial ®)”.
Abstract Platform
Abstracts can only be submitted online.
Abstracts submitted by e-mail or fax will not be considered. The abstract submission system for the ESSO 43 will only be accessible on the congress website.
Step-by-step instructions will be provided within the submission system. Submitters can edit their abstracts until the deadline of 15 May 2024.
Abstract Confirmation
An e-mail confirming receipt of the abstract submitted online will be sent to the presenting author.
An abstract number will be allocated and should be mentioned for any queries relating to the submitted abstract.
Abstract Review
Abstracts submitted for presentation at the ESSO 43 Congress will be reviewed by a panel of experts in the field of the subject and will be judged solely on the data submitted.
The final decision on the presentation format of all selected abstracts lies at the sole discretion of the Scientific Committee.
Abstract topics
Presentation types
Oral Presentation
Abstract is selected for oral presentation in the scientific programme.
Poster Presentation
Abstract will be displayed as a poster on the electronic screens at the venue and will be accessible throughout the whole duration of the congress.
Poster in Spotlight
Abstract will be displayed as a poster on the electronic screens + presented as a short oral presentation in the Posters in Spotlight Session.
Surgical Trial in Progress
Abstracts in all phases of clinical research, ongoing trials that have not reached protocol-specified endpoints for analysis at the time of ESSO 43.
The abstract should include:
- Background
- Methods
- Current status (number of patients already included, target date for analysis and presentation)
Surgical Trial Proposal
Abstracts for ideas or proposals in the advanced stage of development, but not yet open for recruiting patients at the time of ESSO 43.
3 protocol concepts will be selected for presentation in the transversal session: “Clinical Research in Surgical Oncology” [Dragon’s Den] supported by the Anticancer Fund (ACF). The selected authors will have the opportunity to pitch their surgical trial proposal to a panel of experts. The best proposal will be rewarded with a prize of 500 EUR to further develop their protocol. The Anticancer Fund will also support trial presenters’ expenses as per ESSO conditions. Please note that only new research projects will be considered. On-going research will not be considered.
The abstract should include
• Background (main research question, objectives, preliminary data, potential clinical impact)
• Methods (primary and secondary endpoint, study design, analysis plan, sample size, patient population and duration of the study)
• Feasibility (source of funding, target countries)
How to submit
Login
Step 1:
Login on the ESSO Portal.
The ESSO Portal is a completely new portal so the username and password you have used before might not be the same.
If you are a member of the ESSO (registered before December 2023) or you attended ESSO 41 or 42, you are already registered in the portal.
Click on: ‘Don’t remember your username and/or password? Click here.’, to renew your username or password.
If you don’t have an account yet, you can create one by clicking on ‘Sign up’.
If you are logged in please make sure that your account info is still up-to-date. Click on ‘Manage Account’ to edit your account info.
Contact info
Step 2:
Click on the button ‘New Abstract’ to start with an abstract. If you have already made an abstract you can view it and edit here as well. Please note that only saved abstracts can be edited. Once you submit your abstract you can’t edit anymore.
Step 3:
Make sure that the contact info of the presenting author is correct. If yes, click on the tick box below and press ‘next’ to go to the next step.
If the contact info is incorrect, please go back to the congress platform to change the contact info.
Click here to go back to the congress platform [Link].
Abstract Handling
Step 4:
Select the topic of your abstract and your presentation preference. Please note that your preference might not be the actual presentation type of your abstract.
Step 5:
Write down the title of your abstract.
Please be aware of the following:
- The title should be brief and objectively described
- Titles should be in Sentence case – Do not use capital letters in the title except for words that are always capitalized
- Do not use non-standard abbreviations
- Commercial names may not be used in the abstract title (generic names only)
- Do not put a full stop (.) at the end of the sentence
Your title is limited to 200 characters
Click on ‘next’ to go to the next step.
Step 6:
Write your abstract text in the following four sections:
- Background: an introductory sentence indicating the purpose of the study.
- Material and methods: a brief description of pertinent experimental procedures.
- Results (For Surgical Trial Proposals fill in ‘the Feasibility’, for Surgical Trial in Progress fill in the ‘Current status’)
- Conclusions: a statement of the main conclusions (not needed for ‘Surgical trials proposals’, ‘Surgical trials in Progress’)
Step 7:
You will have the opportunity to add up to 9 keywords.
In order to add a keyword click on ‘Add a keyword’, add your keyword and confirm it by clicking on the button again.
When you are done click on ‘Next’.
Disclosure
Step 8:
If you have a potential conflict of interest, please click the button ‘I have potential conflict of interest to disclose’. A conflict of interest can involve: grants, honorarily, shares, paid positions on advisory boards, etc. Please fill in your disclosure statement in the field below. Example: “This abstract is financially supported by an educational grant from [Name of supporter].”
If you don’t have a conflict of interest please click ‘I have no potential conflict of interest to disclose’.
Click on ‘Next’ to the final step.
Confirmation
Step 9:
You will get an overview of your submitted abstract. Please review it, and click on ‘Back’ if you need to make changes. If your abstract is complete and you don’t want to make any changes, click on ‘Submit’. You will receive a confirmation email that we have received your submission. Please note that you can’t edit your abstract anymore when you submit.
If you are not yet finished with your abstract, you can save it as draft. When you log back into the abstract platform, you can edit your abstract. Please do not forget to submit your abstract before the deadline of
15 May 2024, 11:59 PM CEST. Drafted abstracts will not be submitted automatically.
Abstract Selection Notification
The presenting author will receive the result of the review and the Scientific Committee’s decision on their abstract by email by end of June 2024.
Abstract Policies & Regulations
With the submission of an abstract to ESSO 43 Congress, the presenting author:
- Accepts responsibility for the accuracy of the submitted abstract.
- Accepts to be the contact person for all correspondence regarding the abstract and informs co-authors of its status.
- Confirms that all authors are aware of and agree to the content of the abstract and support the data presented.
- Warrants that the data and conclusions presented in the abstract have not been published in the same format and with the same title prior to the date of the ESSO 43 congress.
- States that for all studies involving human or animal subjects, permission has been obtained from the relevant regulatory authority and informed consent given where appropriate.
- Identifies, obtains and discloses any financial interest in products or processes described in the abstract for all abstract authors. This includes stock ownership, membership on an advisory board or board of directors, corporate-sponsored research, and other substantive relationships.
- Releases the copyright on behalf of all authors to ESSO and gives permission for the abstract, when selected for presentation, to be published in an issue of EJSO- the European Journal of Surgical Oncology, as well as on the ESSO 43 website. The copyright of the abstract remains with the author(s).
- Commits to register and attend ESSO 43 if the abstract is selected*. Costs associated with the submission and presentation of an abstract are the responsibility of the presenter. Selected abstracts will only be published in EJSO if the presenting author is registered and attend the Congress in person.
* In case the presenting author is not able or available to present the accepted abstract, a co-author must be appointed to present the abstract and must be registered, please inform the ESSO Secretariat at congress@essoweb.org about this change.